Skip to main content
    C

    Chemomab Therapeutics Ltd DRC (CMMB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.62
    +0.09 (+5.88%)

    Market Cap: $12.31M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    Chemomab Therapeutics Ltd DRC (CMMB) Earnings: Report Dates and Results

    Updated Nov 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Chemomab Therapeutics Ltd DRC (CMMB) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Chemomab Therapeutics Ltd DRC reported EPS of -$1.40. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    68%(17/25)
    Avg Surprise
    +27.08%
    Streak
    5 Q

    Upcoming Estimates

    Reports Mar 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.14
    Range-$0.27 - $0.00
    4 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    CMMB has an expected report date of Mar 17, 2027.

    Earnings History

    Of the 25 quarters below that had an estimate, CMMB beat 17, missed 5 and matched 3. The widest gap in the table came in the quarter ended Mar 31, 2020, when EPS landed 334.78% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$1.40N/AN/AN/AN/AN/AN/A1 up, 0 downNov 6, 2026
    Jun 30, 2026-$1.40N/AN/AN/AN/AN/AN/A1 up, 0 downAug 19, 2026
    Mar 31, 2026$0.00N/AN/AN/AN/AN/AN/A1 up, 0 downMay 14, 2026
    Dec 31, 2025$0.00-$0.01N/A+70.00%BeatN/A10 up, 0 downMar 19, 2026
    Sep 30, 2025$0.00-$0.04-$0.04 - -$0.04+90.00%BeatN/A10 up, 0 downNov 13, 2025
    Jun 30, 2025-$0.02-$0.04-$0.04 - -$0.04+50.00%Beat-140.0%10 up, 0 downAug 14, 2025
    Mar 31, 2025-$0.14-$0.20N/A+30.00%BeatN/A20 up, 0 downMay 15, 2025
    Dec 31, 2024-$0.01-$0.01-$0.01 - -$0.01+20.00%BeatN/A21 up, 0 downMar 3, 2025
    Sep 30, 2024-$0.04-$0.04-$0.04 - -$0.040.00%In lineN/A21 up, 0 downNov 14, 2024
    Jun 30, 2024$0.05-$0.04N/A+225.00%BeatN/AN/AN/AAug 21, 2024
    Mar 31, 2024-$0.06-$0.06N/A0.00%In lineN/AN/A0 up, 0 downMay 9, 2024
    Dec 31, 2023-$0.27-$0.02N/AN/AN/AN/AN/A0 up, 0 downMar 7, 2024
    Sep 30, 2023-$0.07-$0.08-$0.08 - -$0.08+12.50%BeatN/A10 up, 0 downNov 9, 2023
    Jun 30, 2023-$0.14-$0.16N/A+12.50%BeatN/AN/A0 up, 0 downAug 14, 2023
    Mar 31, 2023-$0.16-$0.14-$0.16 - -$0.12-14.29%MissN/A20 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.14-$0.12N/A-16.67%MissN/A10 up, 0 downMar 20, 2023
    Sep 30, 2022-$0.14-$0.92-$2.56 - -$0.08+84.78%BeatN/A20 up, 0 downNov 11, 2022
    Jun 30, 2022-$0.11-$0.72-$1.96 - -$0.08+84.72%BeatN/A20 up, 0 downAug 12, 2022
    Mar 31, 2022-$0.09-$0.68-$1.88 - -$0.08+86.76%BeatN/A20 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.44-$0.40-$1.08 - -$0.08-10.00%MissN/A30 up, 0 downMar 9, 2022
    Sep 30, 2021-$0.05-$0.06-$0.27 - -$0.02+16.67%BeatN/A20 up, 0 downNov 12, 2021
    Jun 30, 2021-$0.05-$0.46-$0.84 - -$0.08+89.13%BeatN/A2N/AAug 13, 2021
    Mar 31, 2021-$0.04-$1.72N/A+97.67%BeatN/AN/AN/AMay 13, 2021
    Dec 31, 2020-$0.06-$1.60N/A+96.25%Beat-100.2%N/AN/AMar 9, 2021
    Sep 30, 2020-$0.09-$0.09N/A0.00%In lineN/AN/AN/ANov 16, 2020
    Jun 30, 2020-$0.09-$0.11N/A+18.18%BeatN/AN/AN/AAug 14, 2020
    Mar 31, 2020-$8.00-$1.84N/A-334.78%MissN/AN/AN/AMay 7, 2020
    Dec 31, 2019$31.20-$2.00N/AN/AN/AN/AN/AN/AMar 17, 2020
    Sep 30, 2019-$34.40-$2.93N/AN/AN/AN/AN/AN/ANov 15, 2019
    Jun 30, 2019-$4.00-$2.64N/A-51.52%MissN/AN/AN/AAug 5, 2019
    Mar 31, 2019-$56.00-$2.56N/AN/AN/AN/AN/AN/AMay 22, 2019
    Dec 31, 2018-$0.12-$0.15N/A+20.00%BeatN/AN/AN/AMar 12, 2019
    Last 32 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.17, after -$0.06 the year before. It was -$69.00 for the year ended Dec 31, 2016, the oldest of the 9 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.17N/A
    Dec 31, 2024-$0.06N/A
    Dec 31, 2023-$0.64N/A
    Dec 31, 2022-$0.48N/A
    Dec 31, 2021-$0.58N/A
    Dec 31, 2020-$8.24N/A
    Dec 31, 2019-$63.20N/A
    Dec 31, 2018-$0.12N/A
    Dec 31, 2016-$69.00N/A

    Frequently Asked Questions About CMMB

    When is Chemomab Therapeutics Ltd DRC's next earnings date?

    Chemomab Therapeutics Ltd DRC's next earnings report is expected for Mar 17, 2027.

    What EPS do analysts expect from CMMB next quarter?

    The consensus EPS estimate for Chemomab Therapeutics Ltd DRC for the quarter ending Dec 31, 2026 is -$0.14 from 4 analysts, with estimates from -$0.27 to $0.00.

    How often does CMMB beat earnings estimates?

    Chemomab Therapeutics Ltd DRC beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of +60.63%.